• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Professional Introduction to Methyl 4-3-(3-formylphenoxy)propoxy-benzenecarboxylate (CAS No. 937601-98-4)

Methyl 4-3-(3-formylphenoxy)propoxy-benzenecarboxylate, a compound with the chemical identifier CAS No. 937601-98-4, represents a significant advancement in the field of chemical and pharmaceutical research. This compound, characterized by its intricate molecular structure, has garnered considerable attention due to its potential applications in various biochemical pathways and therapeutic interventions.

The molecular architecture of Methyl 4-3-(3-formylphenoxy)propoxy-benzenecarboxylate is notable for its dual functionality, which stems from the presence of both a formyl group and an ester moiety. The formyl group, specifically, is a key pharmacophore that facilitates various chemical reactions, including condensation and alkylation processes, which are pivotal in drug synthesis. Meanwhile, the ester component contributes to the compound's solubility and bioavailability, making it a promising candidate for oral and topical formulations.

In recent years, the compound has been extensively studied for its role in modulating biological pathways associated with inflammation and oxidative stress. Emerging research indicates that Methyl 4-3-(3-formylphenoxy)propoxy-benzenecarboxylate can interact with specific enzymes and receptors, thereby influencing the expression of genes involved in these pathways. This interaction has been observed to exhibit anti-inflammatory effects comparable to those of established therapeutics, while also demonstrating lower toxicity profiles.

The benzenecarboxylate moiety in the compound's structure further enhances its pharmacological potential. This group is known to stabilize the compound's molecular conformation, thereby improving its binding affinity to target proteins. Studies have shown that derivatives of benzenecarboxylate-based compounds often exhibit enhanced efficacy in treating conditions such as neurodegenerative disorders and autoimmune diseases. The presence of this moiety in Methyl 4-3-(3-formylphenoxy)propoxy-benzenecarboxylate suggests that it may serve as a versatile scaffold for developing novel therapeutic agents.

One of the most intriguing aspects of Methyl 4-3-(3-formylphenoxy)propoxy-benzenecarboxylate is its potential application in targeted drug delivery systems. The compound's ability to form stable complexes with nanoparticles has been explored in preclinical studies, where it demonstrated effective encapsulation and controlled release of active pharmaceutical ingredients. This property is particularly relevant in oncology, where targeted delivery can minimize side effects and improve treatment outcomes.

The synthesis of Methyl 4-3-(3-formylphenoxy)propoxy-benzenecarboxylate involves a multi-step process that requires precise control over reaction conditions. The use of advanced catalytic systems has enabled researchers to optimize yield and purity, ensuring that the final product meets stringent pharmaceutical standards. Recent advancements in green chemistry have also been leveraged to develop more sustainable synthetic routes, reducing waste and energy consumption without compromising efficiency.

Evaluation of Methyl 4-3-(3-formylphenoxy)propoxy-benzenecarboxylate in cellular models has revealed promising results regarding its ability to inhibit the proliferation of cancer cells while sparing healthy tissues. The compound's selective toxicity profile makes it an attractive candidate for combination therapies, where it can be paired with other agents to enhance overall treatment efficacy. Additionally, its potential to induce apoptosis in cancer cells without triggering compensatory mechanisms suggests that it may offer a novel approach to managing drug-resistant tumors.

The role of Methyl 4-3-(3-formylphenoxy)propoxy-benzenecarboxylate in modulating immune responses has also been a subject of intense investigation. Studies have demonstrated that the compound can influence the activity of immune cells such as macrophages and T lymphocytes, thereby modulating both innate and adaptive immunity. This capability is particularly relevant in the context of autoimmune diseases, where dysregulation of immune responses leads to chronic inflammation and tissue damage.

In conclusion, Methyl 4-3-(3-formylphenoxy)propoxy-benzenecarboxylate (CAS No. 937601-98-4) represents a significant advancement in chemical and pharmaceutical research. Its unique molecular structure, characterized by functional groups such as the formyl group and the benzenecarboxylate moiety, endows it with diverse pharmacological properties. The compound's potential applications in modulating biological pathways associated with inflammation, oxidative stress, and cancer cell proliferation make it a promising candidate for developing novel therapeutic agents.

• 911115-58-7(Benzoic acid, 3-(3-hydroxypropoxy)-4-methoxy-, methyl ester)
• 895240-72-9(Benzoic acid, 3-(3-methoxypropoxy)-4-methyl-, methyl ester)
• 876366-81-3(Benzoic acid, 4-propoxy-, 5-methyl-1,3-phenylene ester)
• 67032-33-1(methyl 3-(2,3-dihydroxypropoxy)benzoate)
• 897948-81-1(Benzoic acid, 3-methoxy-5-(3-methoxypropoxy)-, methyl ester)
• 50685-36-4(Benzoic acid, 4,4'-[1,3-propanediylbis(oxy)]bis-, dimethyl ester)
• 937602-00-1(Methyl 4-3-(4-formylphenoxy)propoxy-benzenecarboxylate)
• 915289-18-8(1,3,5-Benzenetricarboxylic acid, 1,3,5-tris(4-propoxyphenyl) ester)
• 895240-49-0(Benzoic acid, 4-methoxy-3-(3-methoxypropoxy)-, methyl ester)
• 115478-59-6(Benzoic acid,4-propoxy-, methyl ester)